Clinical Trials

The anticoagulation service at SFHMC participates in world wide clinical trials in thromboembolic medicine. For the past ten years, the anticoagulation staff has conducted clinical research for the prophylaxis and treatment of deep vein thrombosis (DVT), treatment of pulmonary embolism (PE) and the treatment of acute stroke. Recently opened studies are now available for patient enrollment.

    1. A study comparing the safety and efficacy of once daily injection of an investigational drug vs adjusted dose intravenous heparin for the treatment of acute symptomatic pulmonary embolism (PE).

    2. A study comparing the safety and efficacy of once daily injection of an investigational drug vs twice daily enoxaparin (LOVENOX) for the treatment of acute symptomatic deep vein thrombosis (DVT).

    3. A study comparing an oral anticoagulant versus standard therapy of enoxaparin(LOVENOX) and warfarin in patients with acute symptomatic deep vein thrombosis (DVT) with or without pulmonary embolism (PE).

These studies have been approved by both the Research Committee and the institution’s Committee for the Protection of Human Subjects (IRB). For additional information or patient screening, call the anticoagulation service.